Related Experiment Video

Updated: Jul 14, 2026

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
05:53

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates

Published on: July 6, 2013

Treatment of congenital cytomegalovirus: where are we now?

Marian G Michaels1

  • 1University of Pittsburgh School of Medicine, Children's Hospital of Pittsburgh, Division of Infectious Diseases, Pittsburgh PA 15213, USA. marian.michaels@chp.edu

Expert Review of Anti-Infective Therapy
|June 6, 2007
PubMed

Insights

Congenital cytomegalovirus (CMV) is a common infection affecting newborns. This review focuses on treatment strategies for symptomatic congenital CMV, which can cause long-term health issues like hearing loss.

Area of Science:

  • Virology
  • Pediatrics
  • Infectious Diseases

Background:

  • Congenital cytomegalovirus (CMV) is the most prevalent congenital infection in the USA, impacting about 1% of newborns.
  • While many infants are asymptomatic, 10% present with symptoms at birth, and 10-15% develop issues within six years.
  • Congenital CMV is the leading cause of nonhereditary sensorineural hearing loss in children.

Purpose of the Study:

  • To review congenital CMV infection.
  • To focus on current and emerging treatment strategies for symptomatic congenital CMV.

Main Methods:

  • Literature review of studies on congenital CMV.
  • Analysis of treatment options for congenital CMV infection.

Main Results:

  • Congenital CMV is a significant public health concern due to its prevalence and potential for long-term sequelae.
  • Sensorineural hearing loss is a primary complication, highlighting the need for effective interventions.
  • Various treatment strategies are being investigated to manage symptomatic congenital CMV.

Conclusions:

  • Effective treatment strategies are crucial for managing symptomatic congenital CMV and preventing long-term complications.
  • Further research into prevention and treatment is warranted to reduce the burden of congenital CMV infection.

More Related Videos

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain05:51

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain

Published on: July 24, 2016

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...